Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Cut by Net Worth Advisory Group

Net Worth Advisory Group lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,588 shares of the medical equipment provider’s stock after selling 40 shares during the period. Net Worth Advisory Group’s holdings in Intuitive Surgical were worth $829,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Bennett Selby Investments LP grew its position in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. Onefund LLC boosted its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC boosted its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. boosted its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 3,031 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total value of $1,749,796.30. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at $203,786.90. The trade was a 89.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the sale, the senior vice president now owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,309 shares of company stock worth $7,611,004 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. UBS Group raised their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Down 6.9 %

NASDAQ ISRG opened at $482.61 on Tuesday. The stock has a market capitalization of $171.90 billion, a PE ratio of 75.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company has a 50 day moving average price of $570.48 and a two-hundred day moving average price of $531.79. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.